Novo Nordisk’s Weight Loss Patent in Litigation – Does Prior Art Threaten US12029779B2?
The patent US12029779B2, assigned to Novo Nordisk A/S, is currently at the center of litigation in two cases: Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc. and Novo Nordisk